Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling.

MLA

Yuan, Juanjuan, et al. “Potentiating CD8+ T Cell Antitumor Activity by Inhibiting PCSK9 to Promote LDLR-Mediated TCR Recycling and Signaling.” Protein & Cell, vol. 12, no. 4, Apr. 2021, pp. 240–60. EBSCOhost, https://doi.org/10.1007/s13238-021-00821-2.

APA

Yuan, J., Cai, T., Zheng, X., Ren, Y., Qi, J., Lu, X., Chen, H., Lin, H., Chen, Z., Liu, M., He, S., Chen, Q., Feng, S., Wu, Y., Zhang, Z., Ding, Y., & Yang, W. (2021). Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein & Cell, 12(4), 240–260. https://doi.org/10.1007/s13238-021-00821-2

Chicago

Yuan, Juanjuan, Ting Cai, Xiaojun Zheng, Yangzi Ren, Jingwen Qi, Xiaofei Lu, Huihui Chen, et al. 2021. “Potentiating CD8+ T Cell Antitumor Activity by Inhibiting PCSK9 to Promote LDLR-Mediated TCR Recycling and Signaling.” Protein & Cell 12 (4): 240–60. doi:10.1007/s13238-021-00821-2.